We are NYBC Ventures, the first venture fund solely dedicated to advancing innovation in blood-related and cellular medicines and technologies.
Taking an agnostic approach to financing vehicles and structures and employing a model of patient capital, we have developed streamlined scientific and investment due diligence teams to evaluate investment and collaborative opportunities in the following areas:
- Benign hematology
- Infectious diseases
- Transfusion medicine
- Cell therapy
- Regenerative medicine
Capitalizing on New York Blood Center Enterprises’ 50+ year history of providing high-quality, cutting-edge blood products and transfusion services to leading medical institutions, we leverage NYBCe’s enterprise-wide leadership, infrastructure, resources, and unparalleled expertise and talent to explore and fund synergistic investment and collaborative opportunities:
Connect with Us
To learn more about NYBC Ventures, please contact Meg Wood, Vice President of Ventures and Business Development.